Target intelligence / Profile preview

Ubiquitin-specific-processing protease 14 (USP14)

Target
USP14
Molecular classification
Enzyme, Deubiquitinase, Cysteine protease, Peptidase C19 family
01

Overview

Ubiquitin-specific-processing protease 14 (USP14) is a major deubiquitinating enzyme (DUB) that reversibly associates with the 19S regulatory particle of the 26S proteasome. It plays a dual role in proteostasis by trimming ubiquitin chains from substrates to facilitate their entry into the proteasome or by inhibiting degradation through premature deubiquitination. USP14 is typically autoinhibited in its free form and becomes catalytically active only upon binding to the proteasome. In oncology, USP14 is frequently overexpressed and contributes to tumor progression by stabilizing oncogenic proteins and inhibiting apoptosis. Conversely, in neurodegenerative contexts, inhibiting USP14 has been shown to accelerate the clearance of misfolded proteins such as tau and ataxin-3. Consequently, USP14 has emerged as a significant therapeutic target, with small-molecule inhibitors like IU1 being developed to modulate protein turnover in various diseases.

Other names
TGTDeubiquitinating enzyme 14Ubiquitin carboxyl-terminal hydrolase 14Ubiquitin thioesterase 1426S proteasome-associated deubiquitinase USP14
02

Mechanism of action

Inhibition of deubiquitinating activity to accelerate proteasomal degradation of substrates or induce proteotoxic stress in cancer cells

03

Biological functions

DeubiquitinationProteasome regulationProtein degradationAutophagy regulationEndoplasmic reticulum-associated degradation (ERAD)Innate immune responseSynaptic development
04

Disease associations

CancerNeurodegenerative diseaseInflammationViral infectionAlzheimer's diseaseParkinson's diseaseAmyotrophic lateral sclerosis
05

Safety considerations

Off-target effects on other deubiquitinating enzymes (e.g., UCHL5)Potential systemic toxicity due to global proteasome modulationChallenges in achieving high selectivity and affinityRisk of proteotoxic stress in non-target tissues
06

Interacting drugs

IU1

4 more in the full profile.

07

Biomarkers

USP14 protein expression levelsUSP14 mRNA expression levelsAccumulation of polyubiquitinated proteinsCOPS5 protein levels

Beyond the preview

Go deeper on Ubiquitin-specific-processing protease 14 (USP14).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin-specific-processing protease 14 (USP14).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call